|
Representatives from the European Medicines Agency, national experts from the European medicines regulatory network, and the European College of Neuropsychopharmacology co-authored a joint commentary in the Lancet: "The Therapeutic Potential of Psychedelics: The European Regulatory Perspective". https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00264-7/fulltext#%20). PAREA welcomes this much needed publication which is an opportunity to open up an institutional debate about moving towards safe, effective and accessible adoption of psychedelic-assisted therapies in Europe.
|
